Vergoeding 2018-2022 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers

  • Raming voor de totale Zvw-populatie
  2018 2019 2020 2021 2022
J05AF01 Zidovudine (Retrovir ®) 32.785 19.823 13.729 18.596 16.763
J05AF02 Didanosine 648 . . . .
J05AF05 Lamivudine (Epivir ®) 529.190 424.470 301.640 229.880 165.600
J05AF06 Abacavir (Ziagen ®) 505.680 385.420 302.520 257.700 215.950
J05AF07 Tenofovirdisoproxil (Viread ®) 2.534.500 994.490 876.800 676.300 634.570
J05AF08 Adefovir (Hepsera ®) 340.800 246.130 190.890 159.190 126.490
J05AF09 Emtricitabine (Emtriva ®) 57.383 50.287 52.636 44.421 40.514
J05AF10 Entecavir (Baraclude ®) 3.425.200 1.484.400 1.641.200 1.326.500 1.441.800
J05AF11 Telbivudine 24.060 20.327 2.504 . .
J05AF13 Tenofoviralafenamide (Vemlidy ®) 519.990 1.101.300 1.595.100 1.790.200 1.959.800
Totaal 7.970.236 4.726.647 4.977.019 4.502.787 4.601.487